Other (Income) Expense, Net

9 Months Ended

Sep. 30, 2020

Component of Operating Income [Abstract]

OTHER (INCOME) EXPENSE, NET

NOTE 16. OTHER (INCOME) EXPENSE, NET

The components of Other (income) expense, net for the three and nine months ended September 30, 2020 and 2019 are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Net gain on sale of business and other assets (1)	$	(1,888)	$	(1,933)	$	(16,730)	$	(3,101)
Foreign currency loss (gain), net (2)	1,332		579		(1,491)		4,336
Net (gain) loss from our investments in the equity of other companies (3)	(2,609)		191		(2,373)		2,546
Other miscellaneous, net (4)	(4,029)		17,366		(4,724)		16,627
Other (income) expense, net	$	(7,194)	$	16,203	$	(25,318)	$	20,408

__________

(1)Amounts primarily relate to the sales of certain intellectual property rights.

(2)Amounts relate to the remeasurement of the Company’s foreign currency denominated assets and liabilities.

(3)Amounts relate to the income statement impacts of our investments in the equity of other companies, including investments accounted for under the equity method.

(4)Amounts during the three and nine months ended September 30, 2019 primarily relate to $17.5 million of contract termination costs incurred as a result of certain product discontinuation activities in our International Pharmaceuticals segment.